PACLITAXEL Labatec 100 mg/16.7ml flac 16.7 ml

7680602280029 CH-60228 L01CD01 07.16.1.
PACLITAXEL Labatec 100 mg/16.7ml flac 16.7 ml
PACLITAXEL Labatec 100 mg/16.7ml flac 16.7 ml
1 / 2
google

Details

Product number
6022802
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
paclitaxelum 100 mg, acidum citricum, macrogolglyceroli ricinoleas 8.785 g, ethanolum anhydricum 6.418 g ad solutionem pro 16.7 ml.

Articles (1)

Paclitaxel Labatec 100 mg/16.7 ml, solution à diluer pour perfusion
Lösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
01/10/2024
Professional SmPC
Français
01/10/2024
Professional SmPC
Italien
01/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
8.785 G Substance HBESI
(N/A)
6.418 G Substance HBESI

Reimbursement information

Public price
CHF 84.35
Specialties list
Yes
Generic
Yes
SL addition date: 01/11/2010

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
60228
Drug name
Paclitaxel Labatec, solution à diluer pour perfusion
Galenic form
KOINF
ATC Code
L01CD01
Authorization status
Z
Dispensation category
A
First authorization
09/04/2010
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine

Packaging details

Description (FR)
PACLITAXEL Labatec 100 mg/16.7ml flac 16.7 ml
Description (DE)
PACLITAXEL Labatec 100 mg/16.7ml Durchstf 16.7 ml
Market launch
09/04/2010
Narcotic (BTM)
No

Original drug

Abraxane, Pulver zur Herstellung einer Infusionsdispersion
CHF 332.10
View original

Other packaging sizes

PACLITAXEL Labatec 30 mg/5ml flac 5 ml
1 DUR
View
PACLITAXEL Labatec 300 mg/50ml flac 50 ml
1 DUR
View